News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Norwood Immunology Limited To Seek IPO In US
November 15, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
15/11/2005 13:53:37. Immune therapy developer and Norwood Abbey (ASX:NAL) subsidiary Norwood Immunology (AIM:NIM) has revealed plans to seek an initial public offering (IPO) in the USA, subject to market conditions. More...
Twitter
LinkedIn
Facebook
Email
Print
IPO
Australia
MORE ON THIS TOPIC
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
April 8, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
April 7, 2026
·
2 min read
·
Heather McKenzie
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
April 6, 2026
·
2 min read
·
Tristan Manalac
